Laura Spanò
YOU?
Author Swipe
View article: Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study Open
View article: Current status and perspectives in immunotherapy for metastatic melanoma
Current status and perspectives in immunotherapy for metastatic melanoma Open
Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing a…
View article: Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma Open
FIGURE 3. Upper, base of an arm of Holotype of Narcissia ahearnae new species, showing marginal plates, abactinal plates, and papular pores. Lower, base of arm of N. trigonaria Sladen, showing marginal plates, abactinal plates, and papular…
View article: Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib Open
The combination of vemurafenib plus fotemustine has clinical activity and an acceptable safety profile in BRAF-refractory patients.